Emerging Insights into TIM-3: A Potential Immune Checkpoint for Lung Cancer Immunotherapeutic Strategies
TIM-3 represents a promising therapeutic target for overcoming resistance to current immunotherapies and improving clinical outcomes in lung cancer. Understanding the regulatory mechanisms of TIM-3 expression provides valuable insights that may guide the development of future therapeutic strategies and precision medicine approaches.
Authors
- Rami Oweis (ORCID: https://orcid.org/0000-0003-2649-7273)
- Subhashree Ray (ORCID: https://orcid.org/0000-0003-0059-7014)
- Mohaned Adil (ORCID: https://orcid.org/0009-0000-9607-0684)
- Ashok Kumar Bishoyi (ORCID: https://orcid.org/0000-0001-6810-2511)
- Abhayveer Singh (ORCID: https://orcid.org/0000-0001-8536-4281)
- Aashna Sinha (ORCID: https://orcid.org/0000-0003-3550-6442)
- Zainab H. Athab (ORCID: https://orcid.org/0009-0007-3736-5205)
- Omer Qutaiba B. Allela (ORCID: https://orcid.org/0000-0001-6803-9794)
- Abdulkareem Shareef
- Suhas Ballal
- Hayder Naji Sameer
- Ahmed Yaseen (ORCID: https://orcid.org/0009-0000-6526-5083)
Institutions
- Jain University (IN)
- Al Noor Hospitals (AE)
- Siksha O Anusandhan University (IN)
- Komar University of Science and Technology (IQ)
- Islamic Azad University of Farahan (IR)
- Ahl Al Bayt University (IQ)
- Uttaranchal University (IN)
- Marwadi University (IN)
- Palestine Ahliya University (PS)
- Modern College of Business and Science (OM)
- University of Kerbala (IQ)
- Al-Farahidi University
- Chitkara University (IN)
Publication Details
- Journal
- Immunological Investigations
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1080/08820139.2025.2571960
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00